Solara Active Pharma Sciences Share Price
₹700.45 -0.95 (-0.14%)
02 Jan, 2025 23:56
Start SIP in SOLARA
Start SIPPerformance
- Low
- ₹686
- High
- ₹713
- 52 Week Low
- ₹323
- 52 Week High
- ₹883
- Open Price₹713
- Previous Close₹701
- Volume125,417
Investment Returns
- Over 1 Month -17.64%
- Over 3 Month -11.28%
- Over 6 Month + 21.29%
- Over 1 Year + 111.53%
Smart Investing Starts Here Start SIP with Solara Active Pharma Sciences for Steady Growth!
Solara Active Pharma Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -5.3
- PEG Ratio
- 0
- Market Cap Cr
- 2,820
- P/B Ratio
- 3
- Average True Range
- 33.34
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -25.41
- RSI
- 42.83
- MFI
- 36.48
Solara Active Pharma Sciences Financials
Solara Active Pharma Sciences Technicals
EMA & SMA
Current Price
₹700.45
-0.95
(-0.14%)
- Bullish Moving Average 8
- Bearish Moving Average 8
- 20 Day
- ₹714.91
- 50 Day
- ₹739.63
- 100 Day
- ₹716.87
- 200 Day
- ₹640.39
Resistance and Support
699.82
- R3 740.63
- R2 726.82
- R1 713.63
- S1 686.63
- S2 672.82
- S3 659.63
Solara Active Pharma Sciences Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-10-21 | Quarterly Results | |
2024-07-22 | Quarterly Results | |
2024-05-29 | Audited Results | |
2024-05-09 | To consider Fund Raising | |
2024-02-14 | Quarterly Results |
Solara Active Pharma Sciences F&O
About Solara Active Pharma Sciences
- NSE Symbol
- SOLARA
- BSE Symbol
- 541540
- Managing Director & CEO
- Mr. Poorvank Purohit
- ISIN
- INE624Z01016
Similar Stocks to Solara Active Pharma Sciences
Solara Active Pharma Sciences FAQs
Solara Active Pharma Sciences share price is ₹700 As on 02 January, 2025 | 23:42
The Market Cap of Solara Active Pharma Sciences is ₹2819.6 Cr As on 02 January, 2025 | 23:42
The P/E ratio of Solara Active Pharma Sciences is -5.3 As on 02 January, 2025 | 23:42
The PB ratio of Solara Active Pharma Sciences is 3 As on 02 January, 2025 | 23:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.